Davidson Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Davidson Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$703K	Buy	12,206 +65	+0.5%	+$3.73K	0.27%	95
2026 Q1	$736K	Buy	12,141 +250	+2%	+$14.6K	0.32%	82
2025 Q4	$641K	Sell	11,891 -1,695	-12%	-$81.5K	0.27%	93
2025 Q3	$613K	Buy	13,586 +1,150	+9%	+$53.7K	0.25%	91
2025 Q2	$576K	Sell	12,436 -1,628	-12%	-$79.9K	0.27%	90
2025 Q1	$858K	Buy	14,064 +1,285	+10%	+$74.9K	0.41%	62
2024 Q4	$723K	Buy	12,779 +222	+2%	+$12.4K	0.37%	65
2024 Q3	$650K	Buy	12,557 +203	+2%	+$9.52K	0.33%	72
2024 Q2	$513K	Buy	12,354 +829	+7%	+$37.1K	0.35%	78
2024 Q1	$625K	Buy	11,525 +563	+5%	+$28.7K	0.36%	73
2023 Q4	$562K	Buy	10,962 +204	+2%	+$10.7K	0.36%	71
2023 Q3	$624K	Buy	10,758 +137	+1%	+$8.39K	0.46%	54
2023 Q2	$679K	Hold	10,621	–	–	0.49%	53
2023 Q1	$736K	Buy	10,621 +2,090	+24%	+$147K	0.57%	47
2022 Q4	$614K	Hold	8,531	–	–	0.54%	49
2022 Q3	$606K	Sell	8,531 -65	-0.8%	-$4.71K	0.58%	48
2022 Q2	$662K	Sell	8,596 -320	-4%	-$24.4K	0.59%	49
2022 Q1	$651K	Sell	8,916 -360	-4%	-$24.2K	0.48%	58
2021 Q4	$578K	Buy	9,276 +331	+4%	+$19.4K	0.4%	67
2021 Q3	$529K	Buy	8,945 +275	+3%	+$18.1K	0.4%	66
2021 Q2	$579K	Sell	8,670 -717	-8%	-$46.8K	0.45%	63
2021 Q1	$592K	Buy	9,387 +60	+0.6%	+$3.73K	0.5%	59
2020 Q4	$577K	Hold	9,327	–	–	0.5%	58
2020 Q3	$561K	Sell	9,327 -70	-0.7%	-$4.21K	0.51%	57
2020 Q2	$552K	Hold	9,397	–	–	0.54%	55
2020 Q1	$523K	Buy	9,397 +607	+7%	+$37.1K	0.65%	47
2019 Q4	$564K	Buy	+8,790	New	+$503K	0.57%	50

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Davidson Trust Company's BMY Position: Q2 2026 in Review

Davidson Trust Company increased its Bristol-Myers Squibb (BMY) stake by 0.54% in Q2 2026, buying an estimated $3.73K and bringing the position to 12,206 shares worth $703K. The position accounts for 0.27% of the portfolio, ranked #95.

Davidson Trust Company first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $858K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Davidson Trust Company held 12,206 shares of Bristol-Myers Squibb worth $703K as of Q2 2026.
Davidson Trust Company bought 65 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.73K.
Bristol-Myers Squibb made up 0.27% of Davidson Trust Company's portfolio in Q2 2026, its #95 holding.
Davidson Trust Company first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
Davidson Trust Company's Bristol-Myers Squibb position peaked at $858K in Q1 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Davidson Trust Company's 13F filing for Q2 2026, filed 29 Jul 2026.